Couldn’t make it to our National Conference? Watch our expert presentations LIVE! For the first time, we live streamed all general sessions, so you can watch as our expert speakers present the latest ovarian cancer updates, from wherever you are. These broadcasts will remain available for viewing for a limited period of time following the original … Continued
(June 19, 2019) In an interview with SurvivorNet, OCRA President and CEO Audra Moran offers some guidance to women who are battling ovarian cancer: #1 – You don’t need to go through it alone. OCRA’s Woman to Woman program matches gynecologic cancer patients with trained survivor volunteers to provide support and mentoring to women when … Continued
(June 18, 2019) Results of new trials, funded in part by OCRA though the Ovarian Cancer Dream Team and published in JAMA Oncology, show that combination niraparib plus pembrolizumab therapy showed promising antitumor activity in patients with ovarian cancer. Patients with recurrent ovarian carcinoma frequently develop resistance to platinum-based chemotherapy, at which time treatment options … Continued
Four multidisciplinary teams to be funded to study survivorship (June 13, 2019) In a new collaboration, the American Cancer Society and Ovarian Cancer Research Alliance have joined forces to fund multidisciplinary research projects to explore new ways of detecting, treating, and preventing ovarian cancer relapse and for improving quality of life among those diagnosed with … Continued
Don’t miss a weekend packed with information and inspiration, July 12-14 in Seattle, Washington! Friday, July 12thWelcome to Seattle! Arrive in early afternoon and catch an optional Seattle Bus Tour, or settle in and get comfortable before you head out to meet new friends at our Newcomers, Community Partners, and Men’s receptions. Catch a special Our … Continued
OCRA is back from the American Society of Clinical Oncology’s annual meeting in Chicago, where doctors and researchers met to discuss the latest in the care of women with ovarian cancer. A few highlights: Progress is being made in the fight against ovarian cancer. Help keep research moving forward with your gift today.
(May 21, 2019) Last night, supporters in NYC packed Carolines on Broadway for Stand Up for Madeline & OCRA, our much-anticipated evening of laughter to end ovarian cancer. Thank you to all who attended this fun night. After guests enjoyed cocktails, hors d’oeuvres and a raucous live auction with the hilarious Judy Gold as auctioneer, … Continued
(May 21, 2019) Earlier this month, Nature Genetics published a study, in part funded by OCRA, that found 34 genes were connected to women developing the earliest stages of ovarian cancer. Using data compiled by the Ovarian Cancer Association Consortium, researchers looked at the genetic profiles of around 25,000 women diagnosed with ovarian cancer and … Continued
Don’t miss your chance to ask ovarian cancer experts your questions! This event has now passed. We hope to see you at a future National Conference! We’re pleased to announce that Ask the Experts, our most popular session at Ovarian Cancer National Conference, has been extended for an extra hour! Survivors, caregivers and supporters will … Continued
(May 20, 2019) University of Chicago gynecologic oncologist Nita K. Lee wants the next generation of doctors to know that the story of ovarian cancer is changing for the better in small and meaningful ways. “I don’t want to sugarcoat this terrible disease, but I also want students to see that women are living longer,” … Continued
(May 14, 2019) We’re excited to announce that Dr. Mary-Claire King, who identified the germline BRCA1 mutation associated with hereditary breast and ovarian cancer, will be a keynote speaker at OCRA’s Ovarian Cancer National Conference! Dr. King is a geneticist and professor at the University of Washington. Her work has helped change the way we … Continued
(May 14, 2019) OCRA received the President’s Award at the first Cancer Community (C2) Awards, created to recognize individuals and organizations who have created positive change in cancer care. The awards – a partnership between AstraZeneca and Scientific American Custom Media – included nominations submitted by organizations from across the cancer ecosystem and participation from … Continued
Get email updates about research news, action alerts, and ways to join the fight.
